Regis Healthcare (ASX:REG) Shares Ease Today: What Could Investors Watch From the FY26 Result?

Sonal Goyal

06 November 2026 06:09 PM AEDT

Regis Healthcare (ASX:REG) Shares Ease Today: What Could Investors Watch From the FY26 Result?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Regis Healthcare (ASX:REG) traded at A$5.01 during the 6 November 2026 session, down 1.38%.
FY26 Revenue from services was A$1,350.6 million, up 16%.
Underlying EBITDA was A$138.0 million, up 10%, with the Margin falling to 10.2%.

Regis Healthcare (ASX:REG) shares were quoted at A$5.01 during the 6 November 2026 trading session, down 1.38%. The S&P/ASX 200 Health Care index (XHJ) eased 0.20% to 35,258.30 during the same session, while the S&P/ASX 200 was down 0.49% at 9,020.80. The session move is not linked to the 24 August 2026 FY26 result. Regis is one of Australia's largest aged care operators, providing residential aged care, home care and retirement services.

Latest Developments

FY26 Financial Results (released 24 August 2026)

Regis reported revenue from services of A$1,350.6 million, up 16% on the prior corresponding period, and underlying EBITDA of A$138.0 million, up 9.7%. The underlying EBITDA margin declined to 10.2% from 10.8%, with staff expenses at 78.1% of revenue from services, up 1.5 percentage points.

About the Company

Regis Healthcare is an ASX-listed aged care operator headquartered in Camberwell, Victoria. It says it serves more than 10,000 older Australians across residential care, home care, day therapy and retirement villages.

Business Overview

Regis earns most of its revenue from residential aged care and home care services. Staff costs are the largest expense, which makes wage settings and staffing levels central to margins.

Sector Context

The S&P/ASX 200 Health Care Index (XHJ) eased 0.20% to 35,258.30 during the same session, while the S&P/ASX 200 was down 0.49% at 9,020.80. Aged care providers are sensitive to government funding, wage costs and workforce availability, and the FY26 release showed staff costs as a key margin driver.

Risks to Watch

Staff costs were 78.1% of revenue from services, and the margin fell in FY26. Government funding and workforce pressures can affect the sector.

Catalysts on Watch

Investors may follow the H1 FY27 result, staffing cost trends and any change in government aged care funding.

Final Takeaways

Regis Healthcare (ASX:REG) traded lower on 6 November 2026 in a session where the health care index eased. Its FY26 result, released on 24 August 2026, reported revenue growth and a lower margin.

FAQs

Q: What was the REG share price on 6 November 2026?

A: Regis Healthcare shares were quoted at A$5.01 during the trading session, down 1.38%.

Q: What was FY26 revenue from services?

A: A$1,350.6 million, up 16%.

Q: What was underlying EBITDA?

A: A$138.0 million, up 9.7%.

Q: Why did the margin fall?

A: Staff expenses were 78.1% of revenue from services, up 1.5 percentage points.

Q: Is the session move linked to the result?

A: No. The result was released on 24 August 2026.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.